Delivery Order SPE2DR25D3301-SPE2DR26F18WW
- Not listed
- The Defense Logistics Agency awarded a $3,649 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price delivery order is expected to be completed by August 12, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gel-One 30 mg/3 mL syringes valued at $9,122.50 with completion scheduled for October 7, 2025. This firm fixed-price delivery order, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, was competitively awarded without set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,490 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 8, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating AmerisourceBergen competed against other...
- The Defense Logistics Agency (DLA) awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, firm fixed-price contract is classified as a non-set-aside delivery order with performance to be completed by October 9, 2025, at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price contract, with an ultimate completion date of September 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $15,382.00 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on December 8, 2025, with completion expected by December 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $4,013.90. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $19,227.50 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price, non-set-aside delivery order is scheduled for completion by December 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18WWDelivery Order
The Defense Logistics Agency (DLA) awarded a $23,073 delivery order to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL). This competitively awarded, firm fixed-price contract was issued on December 3, 2025, with an ultimate completion date of December 24, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant presence in federal medical procurement through its extensive contract portfolio with the DLA and other government healthcare systems. The company's federal awards span a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The Gel-One syringe delivery under this order contributes to the company's ongoing role as a critical vendor for federal medical supply needs, with no set-aside designation applied to this competitive award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 12/2/25 |